Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abnormal, abobotulinumtoxinA, acetate, acetylsalicylic, acnefree, actinic, acuminate, adjournment, adjudication, advantage, AK, Alkem, ambi, amino, Anacor, andolex, anterior, antibiotic, anticipatorily, antigrippin, antimycotic, Antonio, arestin, Ariz, Asian, Atlantic, Austria, bacterial, balding, BB, bench, Bermuda, Biopharm, bioresorbable, Black, boron, Box, Boxed, Cadila, caffeine, caladryl, cefzil, cellulose, Ch, chemistry, China, choroidal, CIS, Citizen, classic, CMS, Cobalt, CODM, commerce, Commonwealth, contributor, corn, cortaid, DEA, Del, denial, dentistry, depth, dermaglow, destination, device, discrimination, distinct, duracef, duty, dysport, EEOC, effectuate, Eisai, emervel, enjoin, evolution, exam, eye, EZ, farmer, FDCA, female, fibrillation, filler, flecainide, floor, fluocinonide, FOB, gastro, gender, Gerot, glabellar, glaucoma, Graceway, HANA, Hanson, HCl, HIPAA, hydroxypropyl, hygiene, hyperpigmentation, imidazole, imiquimod, indemnity, inducing, insert, interference, interpreted, intraocular, Ipsen, isolation, Isotretinoine, Jason, Jelfa, joinder, JSC, JV, JVs, Kazakhstan, KLOX, Korea, Lannach, laser, leaky, lincosamide, lip, Lithuanian, Luliconazole, Luxembourg, Lymphoma, Maker, Maricopa, megace, mentioned, Merlin, migrated, minocycline, molecule, Monster, municipal, muscle, MXN, myopia, necessitated, neovascularization, neurotoxin, Nominee, norgesic, null, obviate, ocular, offensive, ophthalmologist, orapharma, orphenadrine, paracetamol, pathologic, payout, pegaptanib, pen, Penlac, perianal, periodontal, perlane, Pharmascience, pholtex, photoaging, photodynamic, planing, PLN, pocket, podiatry, Portability, prebiotic, Produkt, pruritic, Pure, Pvt, QLT, realistically, red, referencing, referral, refrain, remuneration, reorganization, reprice, Repriced, repricing, rescission, restylane, retinoid, ronald, root, ROW, run, Ryan, sage, salicylic, scaling, scalp, seborrheic, shower, Sidmak, signatory, slightly, Soft, solar, solodyn, solution, Squibb, SRP, Stiefel, streamline, student, subfoveal, subgingival, Sunshine, supposedly, supraventricular, Swint, tachycardia, Taiwan, tambocor, targretin, teeth, tension, texture, therewith, thrombo, timolol, timoptic, tinea, Topco, transparency, treatement, unasserted, underwriting, unpatented, USPTO, Uzbekistan, VELTIN, VELTINTM, verteporfin, vigorously, vii, visudyne, vivo, void, VPI, Weldon, whey, White, whitening, withdrew, ziana, zyclara
Removed:
ACADIA, accept, Adalat, Alzheimer, Amgen, analyzed, Andrx, attract, bed, bid, bioequivalent, BNY, bringing, broader, buyer, calculating, Carolina, CC, cell, Chantilly, Circuit, community, complied, complying, comprising, concerted, conclude, Continuance, Convection, counterpart, CRA, CRD, cycle, delayed, delivering, difficult, Directorate, Dorado, Dublin, Durham, dyskinesia, Edgar, ejaculation, Engleman, enhanced, exploit, fit, forced, genericization, globally, headcount, implementation, improved, imputed, intention, internationally, involving, isomer, la, leased, leasehold, leave, linked, Manitoba, medicinal, Minnesota, mitigation, monopolization, moot, Nevada, night, nil, Nova, observed, opening, opposed, Paddock, permitting, premature, President, Prestwick, Procardia, procedure, proportional, quantity, rationalize, reacquired, reaction, recognizing, reformulation, relationship, residual, safe, Santhera, Scotia, Sherman, shutdown, Sofinnova, SOX, spike, SR, Steinbach, stronger, sun, Syndrome, tendered, Tennessee, theCanada, theCompetition, theIncome, theInvestment, Therapeutix, TITRADOSE, Tourette, TPD, track, tramadol, unchanged, underway, unlisted, unsuccessful, unusual, vacating, vaseretic, vasotec, Virginia, virtually, Wisconsin, withdrawn, XR, zyban
Filing tables
Filing exhibits
Related press release
BHC similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-4 (No. 333-168254) and Forms S-8 (Nos. 333-92229, 333-138697, 333-168629, 333-168254, 333-176205) of Valeant Pharmaceuticals International, Inc. of our report dated February 28, 2011 with respect to the consolidated financial statements and schedule of Valeant Pharmaceuticals International, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2012.
/s/ ERNST & YOUNG LLP | ||
Toronto, Canada February 28, 2013 | Chartered Accountants Licensed Public Accountants |